Paul Diefenhardt (@padiefen) 's Twitter Profile
Paul Diefenhardt

@padiefen

Physician Scientist at University Hospital Cologne // Nephrolab Cologne // CMMC

ID: 1676551320734519300

calendar_today05-07-2023 11:19:42

1 Tweet

6 Followers

25 Following

JASN_News (@jasn_news) 's Twitter Profile Photo
JASN_News
@jasn_news

2 years ago

Modulating T-lymphocytes represents a promising targeted therapeutic option for glomerulonephritis (GN). This study found B and T-lymphocyte attenuator signaling effectively restrained nephritogenic Th1 cells & promoted regulatory T cells bit.ly/JASN0159 Linus Alexander Völker

Modulating T-lymphocytes represents a promising targeted therapeutic option for glomerulonephritis (GN). This study found B and T-lymphocyte attenuator signaling effectively restrained nephritogenic Th1 cells &amp; promoted regulatory T cells bit.ly/JASN0159 <a href="/LinusAlexanderV/">Linus Alexander Völker</a>